CD4 and myelodysplastic syndrome: Clinical responses to immunoregulatory therapy and findings of expanded clonal T lymphocytes have led to the speculation that both CD4+ helper and CD8+ cytotoxic T cells are involved in the immunological pathophysiology of MDS [1], [2], [3].